learn Valproic acid
an anticonvulsant repurposed for hair loss via histone inhibition
Search
forLearn
5 / 801 resultslearn Verteporfin
chemical that might completely regrow follicles from hair transplant extractions
learn Vascular Endothelial Growth Factor
learn Platelet-Rich Plasma
growth factors taken from your blood and injected into your scalp to stimulate hair
learn Setipiprant
Research
5 / 1000+ resultsresearch Provenge is Talk of GU Malignancies Congress
Provenge extends prostate cancer survival by about 4 months.
research Management of Advanced Prostate Cancer Undergoing Major Shift
New treatments are making advanced prostate cancer management more complex but also more hopeful.
research DESENVOLVIMENTO BIOTECNOLÓGICO DE SÉRUM REJUVENESCEDOR ANTIOXIDANTE CONTENDO ATIVO LIPÍDICO ORIUNDO DA RANA CATESBEIANA SHAW
The serum is effective, safe, and stable for skincare.
research BIOMEDICINA ESTÉTICA E AS CONTRIBUIÇÕES DO TRATAMENTO CONTRA QUEDA CAPILAR COM PLASMA RICO EM PLAQUETAS PÓS COVID-19.
Platelet-rich plasma helps treat post-COVID-19 hair loss and boosts self-esteem.
research 1367 The protective role of miR-486 for alopecia areata
miR-486 may help prevent hair loss in alopecia areata.
Community Join
5 / 1000+ resultscommunity Has anyone else seen this encouraging verteporfin case study?
The conversation discusses the potential use of verteporfin for hair loss treatment, with one user mentioning their surgeon's interest in trying it and another noting its research status and clinical use as a YAP inhibitor. Some users debate the market size, availability of generics, and the optimism in the hair loss community regarding new treatments.
community PROMISING Verteporfin day 84 UPDATE - donor hair regeneration human trial
Verteporfin shows promise in donor hair regeneration after 84 days. Combining Finasteride, Minoxidil, and Pyrilutamide with unlimited hair transplants is seen as a potential near-cure for hair loss.
community The story of RU58841/PSK3841
RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.
community Tressless When They See Verteporfin Results
The conversation discusses the potential of Verteporfin, an FDA-approved drug, for hair loss treatment, particularly in combination with microneedling or PRP. Users express hope and curiosity about its application, while some remain cautious due to the need for more extensive testing.
community Verteporfin day 119 update - donor hair regeneration human trial
A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.